TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/HEM

Hemostemix Inc (HEM : TSX-V)

Common Stock

$0.07

CAD

+0.00 (%)

Last updated: 2026-09-09

Get HEM alerts:

HEM

Hemostemix Inc

Source:WealthAwesomeWealthAwesome
$0.01 (15.38%)
30 day period
$0.06$0.07$0.08Jul 20Aug 18Sep 9

Performance

1 Day

+0.00%

1 Week

+7.14%

1 Month

+15.38%

YTD

-16.67%

Key Statistics

Market Cap

$15.86M

52W High

$0.13

52W Low

$0.04

P/E Ratio

-

50 Day MA

$0.07

200 Day MA

$0.07

Beta

0.67

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/9/2026$0.07$0.07$0.07$0.07$0.072,000
9/8/2026$0.07$0.07$0.07$0.07$0.071,653
9/4/2026$0.07$0.07$0.07$0.07$0.072,777
9/3/2026$0.07$0.07$0.07$0.07$0.072,978
9/2/2026$0.07$0.07$0.07$0.07$0.075,001
9/1/2026$0.07$0.07$0.07$0.07$0.0722,844
8/31/2026$0.07$0.07$0.07$0.07$0.0720,400
8/28/2026$0.08$0.08$0.08$0.08$0.080
8/27/2026$0.07$0.08$0.07$0.08$0.0859,000
8/26/2026$0.07$0.07$0.07$0.07$0.071,912

Analyst Price Targets

Based on analyst covering HEM

📈

Wall Street analysts forecast HEM stock price to rise 1180.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.96

+1180.0% Upside

Current Price

C$0.07

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on HEM's historical volatility

HistoricalForecast68%95%
C$0.03C$0.08C$0.14C$0.19C$0.25C$0.31TodayMar 31Jun 15Sep 9Oct 22Dec 5Jan 17

30-Day Vol

100.7%

Annualized

90-Day Vol

115.1%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$0.09

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.08C$0.06C$0.11
60 trading daysC$0.08C$0.05C$0.14
90 trading daysC$0.09C$0.05C$0.16

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Hemostemix Inc

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II clinical trial for the treatment of peripheral arterial disease, chronic limb threatening ischemia, cardiovascular ischemia and angina, and vascular dementia. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-5.06M
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
-0.03
Book Value
-0.03

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About HEM

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
EKGCardioComm Solutions Inc.$0.01+100.00%
PMIPerseverance Metals Inc.$0.94+95.83%
LILL-PLittle Fish Acquisition I Corp.$0.10+66.67%
YAK-HMongolia Growth Group Ltd.$0.04+50.00%
KNEKane Biotech Inc$0.03+50.00%
NBLCNobel29 Resources Corp$0.03+50.00%
ATR-PAster Acquisition Corp.$0.14+47.37%
GSSGossan Resources Ltd$0.04+40.00%

HEM.V news timeline

15 articles covering HEM.V, most recent first

Latest

What's Going On With Hemostemix Inc Stock Thursday?

Stocks

Advertisement